Bank Hapoalim BM’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.85M | Buy |
13,088
+205
| +2% | +$45.5K | 0.44% | 36 |
|
|
2025
Q4 | $2.94M | Sell |
12,883
-264
| -2% | -$60.1K | 0.26% | 45 |
|
|
2025
Q3 | $3.04M | Sell |
13,147
-4,270
| -25% | -$870K | 0.37% | 47 |
|
|
2025
Q2 | $3.23M | Hold |
17,417
| – | – | 0.44% | 47 |
|
|
2025
Q1 | $3.65M | Sell |
17,417
-185
| -1% | -$36K | 0.53% | 41 |
|
|
2024
Q4 | $3.13M | Sell |
17,602
-1,843
| -9% | -$339K | 0.51% | 47 |
|
|
2024
Q3 | $3.84M | Sell |
19,445
-509
| -3% | -$95K | 0.58% | 46 |
|
|
2024
Q2 | $3.42M | Sell |
19,954
-2,159
| -10% | -$358K | 0.48% | 51 |
|
|
2024
Q1 | $4.03M | Sell |
22,113
-738
| -3% | -$127K | 0.52% | 49 |
|
|
2023
Q4 | $3.54M | Sell |
22,851
-830
| -4% | -$121K | 0.48% | 49 |
|
|
2023
Q3 | $3.53M | Sell |
23,681
-6,659
| -22% | -$978K | 0.57% | 45 |
|
|
2023
Q2 | $4.09M | Sell |
30,340
-3,625
| -11% | -$532K | 0.58% | 46 |
|
|
2023
Q1 | $5.41M | Sell |
33,965
-5,145
| -13% | -$787K | 0.75% | 42 |
|
|
2022
Q4 | $6.32M | Sell |
39,110
-846
| -2% | -$130K | 0.79% | 43 |
|
|
2022
Q3 | $5.36M | Sell |
39,956
-1,205
| -3% | -$173K | 0.67% | 45 |
|
|
2022
Q2 | $6.3M | Sell |
41,161
-920
| -2% | -$141K | 0.78% | 40 |
|
|
2022
Q1 | $6.82M | Buy |
42,081
+9,421
| +29% | +$1.37M | 0.71% | 44 |
|
|
2021
Q4 | $4.42M | Buy |
32,660
+2,685
| +9% | +$317K | 0.44% | 59 |
|
|
2021
Q3 | $3.23M | Buy |
29,975
+780
| +3% | +$89.1K | 0.34% | 72 |
|
|
2021
Q2 | $3.29M | Sell |
29,195
-801
| -3% | -$90.2K | 0.37% | 66 |
|
|
2021
Q1 | $3.25M | Sell |
29,996
-65
| -0.2% | -$6.95K | 0.41% | 60 |
|
|
2020
Q4 | $3.22M | Sell |
30,061
-560
| -2% | -$53.8K | 0.45% | 51 |
|
|
2020
Q3 | $2.68K | Sell |
30,621
-1,679
| -5% | -$158K | 0.13% | 43 |
|
|
2020
Q2 | $3.17M | Sell |
32,300
-165
| -0.5% | -$14.5K | 0.74% | 34 |
|
|
2020
Q1 | $2.47M | Buy |
32,465
+4,830
| +17% | +$411K | 0.78% | 31 |
|
|
2019
Q4 | $2.45M | Buy |
27,635
+485
| +2% | +$40.3K | 0.54% | 37 |
|
|
2019
Q3 | $2.03M | Buy |
27,150
+8,610
| +46% | +$590K | 0.5% | 38 |
|
|
2019
Q2 | $1.35M | Buy |
18,540
+3,110
| +20% | +$244K | 0.33% | 55 |
|
|
2019
Q1 | $1.24M | Buy |
15,430
+1,865
| +14% | +$153K | 0.3% | 60 |
|
|
2018
Q4 | $1.25M | Buy |
13,565
+1,630
| +14% | +$143K | 0.4% | 56 |
|
|
2018
Q3 | $1.13M | Buy |
11,935
+5,095
| +74% | +$483K | 0.27% | 72 |
|
|
2018
Q2 | $634K | Buy |
6,840
+1,340
| +24% | +$131K | 0.17% | 105 |
|
|
2018
Q1 | $521K | Sell |
5,500
-465
| -8% | -$51.1K | 0.14% | 113 |
|
|
2017
Q4 | $577 | Buy |
5,965
+545
| +10% | +$51.4K | 0.13% | 122 |
|
|
2017
Q3 | $482K | Sell |
5,420
-250
| -4% | -$19K | 0.11% | 141 |
|
|
2017
Q2 | $411K | Buy |
5,670
+1,150
| +25% | +$77.3K | 0.1% | 144 |
|
|
2017
Q1 | $295K | Buy |
+4,520
| New | +$284K | 0.07% | 159 |
|
Other funds holding ABBV
VCM
VPM
Bank Hapoalim BM's ABBV Position: Q1 2026 in Review
Bank Hapoalim BM increased its AbbVie (ABBV) stake by 1.6% in Q1 2026, buying an estimated $45.5K and bringing the position to 13,088 shares worth $2.85M. The position accounts for 0.44% of the portfolio, ranked #36.
Bank Hapoalim BM first reported a position in ABBV in Q1 2017 and has held it in 37 quarters since. The position peaked at $6.82M in Q1 2022. 4,081 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Bank Hapoalim BM held 13,088 shares of AbbVie worth $2.85M as of Q1 2026.
- Bank Hapoalim BM bought 205 AbbVie shares in Q1 2026, an estimated $45.5K.
- AbbVie made up 0.44% of Bank Hapoalim BM's portfolio in Q1 2026, its #36 holding.
- Bank Hapoalim BM first reported a position in AbbVie in Q1 2017 and has held it in 37 quarters since.
- Bank Hapoalim BM's AbbVie position peaked at $6.82M in Q1 2022.
- 4,081 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Bank Hapoalim BM's 13F filing for Q1 2026, filed 4 May 2026.